HealthHCV is an initiative of HealthHIV that advances hepatitis C (HCV) advocacy, education, and training by:
- Designing and delivering medical and consumer education and training programs to improve the ability of organizations, professionals, and individuals to address the needs of people living with HCV.
- Developing and implementing sound public health policy responsive to the shifting landscape of viral hepatitis and health care in the United States.
- Conducting health service research that identifies trends across viral hepatitis, HIV, and the broader health care landscapes.
HCV remains a worldwide epidemic with over 170 million people chronically infected, and as many as 4.7 million infected with HCV in the United States. Additionally, according to the Centers for Disease Control and Prevention (CDC), 25% of people living with HIV in the U.S. are co-infected with HCV and 80% of people with HIV who inject drugs also have HCV.
While advances in HCV cure therapy have improved, barriers to prevention and treatment of HCV persist. HealthHCV supports a comprehensive approach to HCV prevention, care, and treatment to curb the epidemic, especially as the opioid crisis fuels increases in new infections.